Peter Maag

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
7 years
Director since
2023

7 years of board service in total across 2 boards, counting each seat separately. Longest: CareDx Inc., 3 years.

CareDx Inc. Director
3 years · Since 2023
Kyverna Therapeutics Inc. Director · Chief Executive Officer
2 years · Since 2024

Chief executive roles

Kyverna Therapeutics Inc. · Chief Executive Officer
2024 – 2024 · Former

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 7, 2025 CareDx Inc. Open-market sale −10,000 $18.58 $185,800
Jun 17, 2025 CareDx Inc. Open-market sale −10,000 $19.24 $192,400
Jun 13, 2025 CareDx Inc. Grant or award +12,103 — —
Apr 30, 2025 CareDx Inc. Open-market sale −13,281 $17.23 $228,832
Nov 26, 2024 CareDx Inc. Option exercise +5,000 $12.24 $61,200
Nov 26, 2024 CareDx Inc. Open-market sale −5,000 $25.00 $125,000
Aug 20, 2024 CareDx Inc. Option exercise +26,708 $7.96 $212,596
Aug 20, 2024 CareDx Inc. Open-market sale −8,844 $33.23 $293,886
Aug 20, 2024 CareDx Inc. Open-market sale −13,890 $33.25 $461,843
Aug 20, 2024 CareDx Inc. Open-market sale −12,818 $32.67 $418,764
Jul 8, 2024 CareDx Inc. Grant or award +1,034 — —
Jun 14, 2024 CareDx Inc. Grant or award +10,570 — —
Apr 29, 2024 CareDx Inc. Option exercise +13,281 $5.27 $69,991
Apr 4, 2024 CareDx Inc. Grant or award +1,249 — —
Jan 4, 2024 CareDx Inc. Grant or award +1,525 — —

Questions about Peter Maag

What boards is Peter Maag on?

Peter Maag sits on the boards of CareDx Inc. and Kyverna Therapeutics Inc.

Has Peter Maag been a CEO?

Yes — Peter Maag was CEO of Kyverna Therapeutics Inc. (2024 – 2024).

How long has Peter Maag served on boards?

Our records show at least 7 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.